🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Aier Eye Hospital Group Co., Ltd. (SHE:300015)
China flag China · Delayed Price · Currency is CNY
9.02
-0.06 (-0.66%)
Nov 20, 2026, 9:25 AM CST

Aier Eye Hospital Group Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
23,14122,28120,91020,31316,06914,973
Other Revenue
71.5871.5872.8354.341.1227.91
23,21322,35320,98320,36716,11015,001
Revenue Growth
4.73%6.53%3.02%26.43%7.39%25.93%
Cost of Revenue
12,67811,82310,88710,0227,9817,212
Gross Profit
10,53510,53010,09610,3458,1297,788
Selling, General & Admin
5,0725,3615,1434,6383,8513,406
Research & Development
248.6299.81317.98331.32269.9221.18
Other Operating Expenses
80.0649.1863.3745.6544.6241.32
Operating Expenses
5,4665,8355,6415,1224,2433,766
Operating Income
5,0694,6954,4555,2233,8874,022
Interest Expense
-277.84-269.72-255.56-194.82-177.65-164.66
Interest & Investment Income
124.62147.31309.27165.73131.56199.53
Currency Exchange Gain (Loss)
71.371.3-10.3452.41128.9742.88
Other Non Operating Income (Expenses)
-60.87-68.94-40.24-54.19-38.19-44.93
EBT Excluding Unusual Items
4,9274,5754,4585,1923,9314,055
Impairment of Goodwill
-155.97-155.97-187.7-383.61-95.34-216.66
Gain (Loss) on Sale of Investments
28.2398.29334.4-79.42-356.89-448.39
Gain (Loss) on Sale of Assets
7.639.824.270.71-1.250.05
Asset Writedown
-157.63-8.2-6.82-6.11-5.01-4.27
Other Unusual Items
-280.95-93.55-8.24-172.76-137.88-237.77
Pretax Income
4,3684,4254,5944,5513,3353,148
Income Tax Expense
1,705951.92858.15895.02646.06677.85
Earnings From Continuing Operations
2,6633,4733,7363,6562,6892,470
Minority Interest in Earnings
-239.43-232.96-180.07-297.12-164.77-146.56
Net Income
2,4233,2403,5563,3592,5242,323
Net Income to Common
2,4233,2403,5563,3592,5242,323
Net Income Growth
-24.72%-8.88%5.87%33.06%8.65%34.78%
Shares Outstanding (Basic)
9,3089,2689,2449,2189,0479,054
Shares Outstanding (Diluted)
9,3089,2689,2449,2519,0609,054
Shares Change
0.46%0.27%-0.07%2.10%0.07%1.48%
EPS (Basic)
0.260.350.380.360.280.26
EPS (Diluted)
0.260.350.380.360.280.26
EPS Growth
-25.07%-9.12%5.95%30.33%8.57%32.82%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
3,4413,8803,0524,4123,1022,590
Free Cash Flow Per Share
0.370.420.330.480.340.29
Dividend Per Share
0.1000.1800.1600.1500.0770.071
Dividend Growth
-58.34%12.48%6.67%95.09%8.31%3.65%
Gross Margin
45.38%47.11%48.12%50.79%50.46%51.92%
Operating Margin
21.84%21.00%21.23%25.64%24.13%26.81%
Profit Margin
10.44%14.50%16.95%16.49%15.67%15.49%
Free Cash Flow Margin
14.83%17.36%14.54%21.66%19.26%17.27%
EBITDA
5,9955,5865,3015,9114,5074,511
EBITDA Margin
25.82%24.99%25.26%29.02%27.97%30.07%
D&A For EBITDA
925.09891.16845.92687.72619.79489.23
EBIT
5,0694,6954,4555,2233,8874,022
EBIT Margin
21.84%21.00%21.23%25.64%24.13%26.81%
Effective Tax Rate
39.04%21.51%18.68%19.67%19.37%21.53%
Revenue as Reported
23,21322,35320,98320,36716,11015,001
Advertising Expenses
-963.33987.95937.29723.56-